Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis

by Manosuthi W., Sungkanuparph S., Anekthananon T., Supparatpinyo K., Nolen T.L., Zimmer L.O., Pappas P.G., Larsen R.A., Filler S.G., Chetchotisakd P.
Published 2014

Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients

by Anekthananon T., Manosuthi W., Chetchotisakd P., Kiertiburanakul S., Supparatpinyo K., Ratanasuwan W., Pappas P.G., Filler S.G., Kopetskie H.A., Nolen T.L., Kendrick A.S., Larsen R.A.
Published 2014

A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis

by Pappas P.G., Chetchotisakd P., Larsen R.A., Manosuthi W., Morris M.I., Anekthananon T., Sungkanuparph S., Supparatpinyo K., Nolen T.L., Zimmer L.O., Kendrick A.S., Johnson P., Sobel J.D., Filler S.G.
Published 2014

Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: A prospective multicenter study

by Sungkanuparph S., Filler S.G., Chetchotisakd P., Pappas P.G., Nolen T.L., Manosuthi W., Anekthananon T., Morris M.I., Supparatpinyo K., Kopetskie H., Kendrick A.S., Johnson P.C., Sobel J.D., Larsen R.A.
Published 2014